Self‐Assembling Synthetic Congener Collagen Mini‐Fibrils With Genetically Encoded Hydroxyproline and 3,4‐Dihydroxyphenylalanine for Wound Healing
Journal of Biomedical Materials Research Part A · 2025
DOI: 10.1002/jbm.a.38014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2025. Verfasst von Ashokraj Sundarapandian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR)-CLRI, Chennai, India. Hauptthemen laut MEDLINE: Wound Healing, Collagen, Hydroxyproline, Dihydroxyphenylalanine. Die Arbeit nennt 48 Literaturangaben.
Themen: Wundversorgung
Abstract (Originalsprache)
Collagen‐like proteins (CLPs) and their congeners can form stable triple helices but show limited fibril‐forming ability, restricting their application as biomaterials. To more closely replicate the structural features of natural collagen, we engineered an extended CLP‐CLP double domain (CLPdd) genetically encoded with Hydroxyproline (CLPdd‐Hyp) and 3,4‐dihydroxyphenylalanine (CLPdd‐DOPA) using a genetic code expansion strategy. This study presents the first report of the dual incorporation of Hydroxyproline (Hyp) and 3,4‐dihydroxyphenylalanine (DOPA) into the CLP double domain (CLPdd), yielding the variant CLPdd‐HD, which exhibited significantly enhanced fibrillation, thermal stability, and biomaterial potential. Among the engineered variants, CLPdd‐Hyp showed the most pronounced improvements in triple‐helical structure, fibrillation behavior, wound healing efficacy, and cell adhesion highlighting its promise as a biomaterial. Biocompatibility assessments further confirmed the suitability of CLPdd variants for biomedical applications. Notably, CLPdd‐HD demonstrated exceptional thermal stability and cell‐adhesive properties, underscoring its potential for further optimization. This work lays a foundation for tailoring bacterial CLPs through strategic NCAA incorporation, opening new avenues for developing advanced collagen‐mimetic biomaterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biochemistry and Biotechnology, Council of Scientific and Industrial Research (CSIR)-CLRI, Chennai, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
- Department of Biotechnology, Easwari Engineering College, Chennai, India.
- Division of Organic and Bioorganic Chemistry, Council of Scientific and Industrial Research (CSIR)-CLRI, Chennai, India.
- Advanced Materials Laboratory, Council of Scientific and Industrial Research (CSIR)-CLRI, Chennai, India.
Zitieren
APA
Sundarapandian, A., Pachaiyappan, M., Aarthy, M., Jangra, S., Shanmugam, G., Anandasadagopan, S. K., Jaganathan, M., & Ayyadurai, N. (2025). Self‐Assembling Synthetic Congener Collagen Mini‐Fibrils With Genetically Encoded Hydroxyproline and 3,4‐Dihydroxyphenylalanine for Wound Healing. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.38014
Vancouver
Sundarapandian A, Pachaiyappan M, Aarthy M, Jangra S, Shanmugam G, Anandasadagopan SK, et al. Self‐Assembling Synthetic Congener Collagen Mini‐Fibrils With Genetically Encoded Hydroxyproline and 3,4‐Dihydroxyphenylalanine for Wound Healing. Journal of Biomedical Materials Research Part A. 2025. doi:10.1002/jbm.a.38014
BibTeX
@article{Sundarapandian2025,
author = {Sundarapandian, Ashokraj and Pachaiyappan, Mohandass and Aarthy, Mayilvahanan and Jangra, Sonam and Shanmugam, Ganesh and Anandasadagopan, Suresh Kumar and Jaganathan, Maheshkumar and Ayyadurai, Niraikulam},
title = {Self‐Assembling Synthetic Congener Collagen Mini‐Fibrils With Genetically Encoded Hydroxyproline and 3,4‐Dihydroxyphenylalanine for Wound Healing},
journal = {Journal of Biomedical Materials Research Part A},
year = {2025},
doi = {10.1002/jbm.a.38014}
}
EUVIMED